Select Biotechnology Portfolio ABBV Holdings History
Select Biotechnology Portfolio's AbbVie Inc Holding Summary
As of 2025-02-28, Select Biotechnology Portfolio held 3.07 Mil shares of AbbVie Inc(ABBV), totaling $641.56 Mil. This investment constitutes 15.16% of their stock portfolio, and Select Biotechnology Portfolio now holds 0.17% of the outstanding AbbVie Inc(ABBV) stock.
The initial trade took place in 2021Q4. And since then Select Biotechnology Portfolio has made 8 purchases of ABBV, at an average price of $133.77, for a total of 4.68 Mil shares. In addition, there have been 6 sales at an average price of $160.56 for 1.61 Mil shares. Based on historical transaction data and ABBV's current price of $191.40, Select Biotechnology Portfolio's estimated gain on his ABBV holdings is $220.02 Mil, reflecting a 35.14% gain to date.
Select Biotechnology Portfolio ABBV ($191.40) Holding Chart
Select Biotechnology Portfolio ABBV ($191.40) Quarterly Buys and Sells
Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
---|---|---|---|---|
Shares Bought | 0 | Average Price $-/Share | ||
Shares Sold | 0 | Average Price $-/Share | ||
Current Price $0.00 | Total Estimated Gain 0 % |
Top Ranked Articles
- 1